BRPI1011710A8 - lágrimas artificiais e usos trapêuticos - Google Patents
lágrimas artificiais e usos trapêuticos Download PDFInfo
- Publication number
- BRPI1011710A8 BRPI1011710A8 BRPI1011710A BRPI1011710A BRPI1011710A8 BR PI1011710 A8 BRPI1011710 A8 BR PI1011710A8 BR PI1011710 A BRPI1011710 A BR PI1011710A BR PI1011710 A BRPI1011710 A BR PI1011710A BR PI1011710 A8 BRPI1011710 A8 BR PI1011710A8
- Authority
- BR
- Brazil
- Prior art keywords
- oil
- artificial tears
- traumatic
- syndrome
- dog
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/47—Euphorbiaceae (Spurge family), e.g. Ricinus (castorbean)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/55—Linaceae (Flax family), e.g. Linum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/04—Artificial tears; Irrigation solutions
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Ophthalmology & Optometry (AREA)
- Dispersion Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Materials For Medical Uses (AREA)
Abstract
"lágrimas artificiais e usos trapêuticos". a presente invenção refere-se a composições oftálmicas, por exemplo lágrimas artificiais, apropriadas para o tratamento da síndrome do olho seco em um ser humano ou outro mamífero sofrendo de tal síndrome, por exemplo, um cachorro ou gato, que compreende uma mistura de óleo de mamona com outro óleo, por exemplo, um óleo alimentício, por exemplo azeite de oliva, óleo de gergelim, óleo de milho e etc.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US18433909P | 2009-06-05 | 2009-06-05 | |
US61/184,339 | 2009-06-05 | ||
PCT/US2010/037153 WO2010141648A2 (en) | 2009-06-05 | 2010-06-03 | Artificial tears and therapeutic uses |
Publications (4)
Publication Number | Publication Date |
---|---|
BRPI1011710A2 BRPI1011710A2 (pt) | 2016-03-22 |
BRPI1011710A8 true BRPI1011710A8 (pt) | 2019-11-05 |
BRPI1011710B1 BRPI1011710B1 (pt) | 2021-01-26 |
BRPI1011710B8 BRPI1011710B8 (pt) | 2021-05-25 |
Family
ID=42312750
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI1011710A BRPI1011710B8 (pt) | 2009-06-05 | 2010-06-03 | composição para ser usada como uma lágrima artificial |
Country Status (24)
Country | Link |
---|---|
US (6) | US8496976B2 (pt) |
EP (1) | EP2437762B1 (pt) |
KR (1) | KR101778316B1 (pt) |
CN (2) | CN104906170A (pt) |
AU (1) | AU2010256652B2 (pt) |
BR (1) | BRPI1011710B8 (pt) |
CA (1) | CA2764802A1 (pt) |
DK (1) | DK2437762T3 (pt) |
ES (1) | ES2646338T3 (pt) |
HK (1) | HK1214943A1 (pt) |
HR (1) | HRP20171691T1 (pt) |
HU (1) | HUE034213T2 (pt) |
IL (1) | IL216800A (pt) |
LT (1) | LT2437762T (pt) |
MX (2) | MX358504B (pt) |
MY (1) | MY172185A (pt) |
NO (1) | NO2437762T3 (pt) |
NZ (1) | NZ596932A (pt) |
PL (1) | PL2437762T3 (pt) |
PT (1) | PT2437762T (pt) |
RU (1) | RU2589837C2 (pt) |
SI (1) | SI2437762T1 (pt) |
WO (1) | WO2010141648A2 (pt) |
ZA (1) | ZA201108979B (pt) |
Families Citing this family (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8569367B2 (en) | 2004-11-16 | 2013-10-29 | Allergan, Inc. | Ophthalmic compositions and methods for treating eyes |
AU2010256652B2 (en) | 2009-06-05 | 2015-11-26 | Allergan, Inc. | Artificial tears and therapeutic uses |
US8957048B2 (en) | 2011-10-06 | 2015-02-17 | Allergan, Inc. | Compositions for the treatment of dry eye |
US9907826B2 (en) | 2011-12-07 | 2018-03-06 | Allergan, Inc. | Efficient lipid delivery to human tear film using a salt-sensitive emulsion system |
HUE049489T2 (hu) | 2011-12-07 | 2020-09-28 | Allergan Inc | Hatékony lipidbevitel emberi könnyfilmbe sóérzékeny emulziós rendszer alkalmazásával |
US9278132B2 (en) * | 2012-02-13 | 2016-03-08 | Bausch & Lomb Incorporated | Ophthalmic pharmaceutical compositions and methods of making and using same |
WO2013142912A1 (en) * | 2012-03-30 | 2013-10-03 | Brien Holden Vision Institute | Methods and compositions for reducing ocular discomfort |
US9289494B2 (en) | 2013-11-20 | 2016-03-22 | RestorTears, LLC | Method of treating ocular disorders with compounds found in Harderian gland secretions |
CA2994222C (en) | 2014-08-20 | 2020-09-08 | Silk Technologies, Ltd. | Fibroin-derived protein composition |
US10279005B2 (en) * | 2014-11-25 | 2019-05-07 | Allergan, Inc. | Stabilized omega-3 ophthalmic compositions |
EP3362096B1 (en) | 2015-10-14 | 2023-12-13 | Paul Gavaris | Ophthalmic treatment composition and vehicle for delivery of pharmaceutical substances or therapeutic agents |
SG11201808804TA (en) | 2016-04-08 | 2018-11-29 | Univ Cornell | A method to enhance wound healing using silk-derived protein |
WO2019005139A1 (en) * | 2017-06-30 | 2019-01-03 | Jenivision Inc. | FORMULATIONS FOR HAIR GROWTH |
EP3266446B1 (en) * | 2016-07-07 | 2018-11-21 | Laboratorios SALVAT, S.A. | Ophthalmic composition comprising castor oil and medium chain triglyceride |
MX2019001633A (es) | 2016-08-12 | 2019-09-18 | Silk Tech Ltd | Proteina derivada de la seda para el tratamiento de la inflamacion. |
CN109689161A (zh) * | 2016-08-19 | 2019-04-26 | 阿克里维斯塔有限责任公司 | 诊断和治疗干眼综合症的方法以及用于治疗人眼的组合物 |
GB201618175D0 (en) * | 2016-10-27 | 2016-12-14 | Warneford Healthcare Ltd | Pharmaceutical compositions |
JP7311160B2 (ja) | 2017-08-18 | 2023-07-19 | アクリビスタ エルエルシー | ドライアイ症候群を診断及び処置する方法及びヒトの眼を処置するための組成物 |
US11166997B2 (en) | 2018-07-27 | 2021-11-09 | Johnson & Johnson Surgical Vision, Inc. | Compositions and methods for treating the eye |
WO2020021481A1 (en) | 2018-07-27 | 2020-01-30 | Johnson & Johnson Vision Care, Inc. | Compositions and methods for treating the eye |
US10966948B2 (en) | 2019-07-23 | 2021-04-06 | Johnson & Johnson Surgical Vision, Inc. | Compositions and methods for treating the eye |
BR112021000634A2 (pt) | 2018-07-27 | 2021-04-06 | Johnson & Johnson Surgical Vision, Inc. | Composições e métodos para tratar os olhos |
US11197841B2 (en) | 2019-07-23 | 2021-12-14 | Johnson & Johnson Surgical Vision, Inc. | Compositions and methods for treating the eye |
EP3829614A2 (en) | 2018-07-27 | 2021-06-09 | Johnson & Johnson Surgical Vision, Inc. | Compositions and methods for treating the eye |
BR112021000724A2 (pt) | 2018-07-27 | 2021-04-13 | Johnson & Johnson Surgical Vision, Inc. | Composições e métodos para tratar os olhos |
US11045416B2 (en) | 2018-08-30 | 2021-06-29 | Johnson & Johnson Consumer Inc. | Topical compositions comprising Pichia anomala and retinol |
US11110051B2 (en) | 2018-08-30 | 2021-09-07 | Johnson & Johnson Consumer Inc. | Topical compositions comprising Pichia anomala and n-acetyl glucosamine |
KR20210009947A (ko) | 2019-07-18 | 2021-01-27 | 윤영선 | 산소가 도입된 점안제, 및 그 제조방법 |
EP3824877A1 (en) | 2019-11-19 | 2021-05-26 | Johnson & Johnson Consumer Inc. | Compositions and methods for treating the eye |
US11969451B2 (en) | 2019-11-19 | 2024-04-30 | Johnson & Johnson Surgical Vision, Inc. | Compositions and methods for treating the eye |
US11969454B2 (en) | 2019-11-19 | 2024-04-30 | Johnson & Johnson Surgical Vision, Inc. | Compositions and methods for treating the eye |
CN112823789B (zh) | 2019-11-19 | 2024-05-10 | 强生外科视力公司 | 用于治疗眼睛的组合物和方法 |
EP4059508A1 (en) | 2021-03-19 | 2022-09-21 | Johnson & Johnson Consumer Inc. | Methods of using compositions comprising an iceland moss extract |
Family Cites Families (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS56104814A (en) * | 1980-01-25 | 1981-08-20 | Kunihiro Okanoe | Preparation of eye drop |
US4649047A (en) | 1985-03-19 | 1987-03-10 | University Of Georgia Research Foundation, Inc. | Ophthalmic treatment by topical administration of cyclosporin |
WO1989001772A1 (en) | 1987-09-03 | 1989-03-09 | University Of Georgia Research Foundation, Inc. | Ocular cyclosporin composition |
US4839342A (en) | 1987-09-03 | 1989-06-13 | University Of Georgia Research Foundation, Inc. | Method of increasing tear production by topical administration of cyclosporin |
CH679210A5 (pt) * | 1988-10-26 | 1992-01-15 | Sandoz Ag | |
US5474979A (en) * | 1994-05-17 | 1995-12-12 | Allergan, Inc. | Nonirritating emulsions for sensitive tissue |
AU1172097A (en) | 1995-12-27 | 1997-07-28 | Rohto Pharmaceutical Co., Ltd. | Pharmaceutical composition containing trehalose |
US5981607A (en) * | 1998-01-20 | 1999-11-09 | Allergan | Emulsion eye drop for alleviation of dry eye related symptoms in dry eye patients and/or contact lens wearers |
GB0012597D0 (en) | 2000-05-25 | 2000-07-12 | Astrazeneca Ab | Formulation |
US7027446B2 (en) | 2001-07-18 | 2006-04-11 | P-Cube Ltd. | Method and apparatus for set intersection rule matching |
JP4284491B2 (ja) | 2002-07-16 | 2009-06-24 | 豊和工業株式会社 | ピストン外形の加工データ生成装置 |
TWI335819B (en) * | 2002-12-24 | 2011-01-11 | Alcon Inc | Use of oculosurface selective glucocorticoid in the treatment of dry eye |
ES2414084T3 (es) * | 2003-02-24 | 2013-07-18 | Pharmaceutical Productions Inc. | Sistema de administración de fármacos por vía transmucosa |
US20040185068A1 (en) | 2003-03-18 | 2004-09-23 | Zhi-Jian Yu | Self-emulsifying compositions, methods of use and preparation |
US20060251685A1 (en) | 2003-03-18 | 2006-11-09 | Zhi-Jian Yu | Stable ophthalmic oil-in-water emulsions with Omega-3 fatty acids for alleviating dry eye |
RU2007103835A (ru) | 2004-07-01 | 2008-08-10 | Шепенс Ай Рисерч (Us) | Композиции и способы лечения заболеваний и нарушений состояния глаз |
JPWO2006022291A1 (ja) * | 2004-08-27 | 2008-05-08 | 千寿製薬株式会社 | ドライアイ治療用点眼液 |
US8569367B2 (en) * | 2004-11-16 | 2013-10-29 | Allergan, Inc. | Ophthalmic compositions and methods for treating eyes |
CN100562340C (zh) * | 2005-06-17 | 2009-11-25 | 中国科学院上海药物研究所 | 一种微乳型人工泪液 |
US7297679B2 (en) | 2005-07-13 | 2007-11-20 | Allergan, Inc. | Cyclosporin compositions |
US7202209B2 (en) | 2005-07-13 | 2007-04-10 | Allergan, Inc. | Cyclosporin compositions |
US7288520B2 (en) | 2005-07-13 | 2007-10-30 | Allergan, Inc. | Cyclosporin compositions |
WO2008035246A2 (en) | 2006-07-28 | 2008-03-27 | Novagali Pharma Sa | Compositions containing quaternary ammonium compounds |
WO2008027341A2 (en) * | 2006-08-30 | 2008-03-06 | Merck & Co., Inc. | Topical ophthalmic formulations |
WO2008106228A2 (en) | 2007-02-28 | 2008-09-04 | Aciex Therapeutics, Inc. | Methods and compositions for normalizing meibomian gland secretions |
CN101554369B (zh) * | 2008-05-12 | 2012-07-25 | 陈亚玲 | 一种外用复合油纳米乳喷雾剂和滴眼剂及其制备方法 |
UA36915U (uk) * | 2008-05-28 | 2008-11-10 | Львівський Національний Медичний Університет Ім. Данила Галицького | Очні краплі для лікування запальних захворювань судинної оболонки та сухого кератокон'юнктивіту, які викликані аутоімунними процесами |
IT1393419B1 (it) | 2009-03-19 | 2012-04-20 | Medivis S R L | Composizioni oftalmiche a base di acidi grassi polinsaturi omega-3 e omega-6. |
US9480645B2 (en) | 2009-06-02 | 2016-11-01 | Abbott Medical Optics Inc. | Omega-3 oil containing ophthalmic emulsions |
AU2010256652B2 (en) | 2009-06-05 | 2015-11-26 | Allergan, Inc. | Artificial tears and therapeutic uses |
-
2010
- 2010-06-03 AU AU2010256652A patent/AU2010256652B2/en active Active
- 2010-06-03 MY MYPI2012000497A patent/MY172185A/en unknown
- 2010-06-03 NO NO10724631A patent/NO2437762T3/no unknown
- 2010-06-03 RU RU2011151468/15A patent/RU2589837C2/ru active
- 2010-06-03 NZ NZ596932A patent/NZ596932A/en unknown
- 2010-06-03 PL PL10724631T patent/PL2437762T3/pl unknown
- 2010-06-03 MX MX2014012100A patent/MX358504B/es unknown
- 2010-06-03 CN CN201510225116.XA patent/CN104906170A/zh active Pending
- 2010-06-03 US US13/376,374 patent/US8496976B2/en active Active
- 2010-06-03 CA CA2764802A patent/CA2764802A1/en not_active Abandoned
- 2010-06-03 ES ES10724631.6T patent/ES2646338T3/es active Active
- 2010-06-03 BR BRPI1011710A patent/BRPI1011710B8/pt active IP Right Grant
- 2010-06-03 KR KR1020127000233A patent/KR101778316B1/ko active IP Right Grant
- 2010-06-03 CN CN2010800348429A patent/CN102458430A/zh active Pending
- 2010-06-03 HU HUE10724631A patent/HUE034213T2/en unknown
- 2010-06-03 PT PT107246316T patent/PT2437762T/pt unknown
- 2010-06-03 EP EP10724631.6A patent/EP2437762B1/en not_active Revoked
- 2010-06-03 SI SI201031575T patent/SI2437762T1/en unknown
- 2010-06-03 WO PCT/US2010/037153 patent/WO2010141648A2/en active Application Filing
- 2010-06-03 MX MX2011013007A patent/MX2011013007A/es active IP Right Grant
- 2010-06-03 DK DK10724631.6T patent/DK2437762T3/da active
- 2010-06-03 LT LTEP10724631.6T patent/LT2437762T/lt unknown
-
2011
- 2011-12-06 IL IL216800A patent/IL216800A/en active IP Right Grant
- 2011-12-07 ZA ZA2011/08979A patent/ZA201108979B/en unknown
-
2013
- 2013-06-28 US US13/931,281 patent/US8679554B2/en active Active
-
2014
- 2014-01-28 US US14/166,589 patent/US9821020B2/en active Active
-
2016
- 2016-03-14 HK HK16102876.7A patent/HK1214943A1/zh unknown
-
2017
- 2017-10-23 US US15/791,158 patent/US11045515B2/en active Active
- 2017-11-06 HR HRP20171691TT patent/HRP20171691T1/hr unknown
-
2021
- 2021-05-25 US US17/329,586 patent/US20220008496A1/en not_active Abandoned
-
2023
- 2023-08-03 US US18/364,692 patent/US20240108677A1/en active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI1011710A8 (pt) | lágrimas artificiais e usos trapêuticos | |
BR112012006692A2 (pt) | composição farmacêutica compreendendo ácido graxo de omega-3 e um derivado de hidróxi de uma estatina e métodos de uso das mesmas | |
ECSP12012211A (es) | Composiciones de anticuerpos anti-factor de crecimiento nervioso (ngf) | |
BR112013007314A2 (pt) | anticorpos anti-cd48 e seus usos | |
EA202091999A3 (ru) | Применение ингибиторов dpp iv | |
ATE551063T1 (de) | Verwendung von bifidobacterium longum zur prophylaxe und behandlung von entzündungen | |
MA35458B1 (fr) | Variants du facteur de croissance des fibroblastes 21 | |
IL186741A0 (en) | Optical probe for delivery of light | |
ATE456369T1 (de) | Flibanserin zur behandlung von harninkontinenz und assoziierten erkrankungen | |
MX2011013060A (es) | Formulaciones oftalmicas, metodos de preparacion y metodos para utilizarlas. | |
GT200900146A (es) | Inhibidores de la actividad de la akt | |
BRPI0717845A2 (pt) | Uso de compostos, composições farmacêuticas e métodos para o tratamento e/ou profilaxia de enfermidades que podem ser tratadas com agentes de elevação de colesterol-hdl e compostos | |
BRPI0715932A2 (pt) | composiÇÕes para tratamentos dos cabelos ou pÊlos que podem melhorar a aparÊncia dos cabelos ou pÊlos, tornando-os mais espessos e mais cheios | |
BR112014014410A2 (pt) | composições e métodos que compreendem uma variante de enzima lipolítica | |
GT200600254A (es) | Moduladores de aminoquinolina y aminoquinazolina quinasa | |
BR112015006055A2 (pt) | composições e métodos para o tratamento e prevenção de lesão tecidual e doença | |
BR112013004436A2 (pt) | composições e usos de materiais com atividade microbicida alta e toxicidade baixa | |
BR112014015271A2 (pt) | produto absorvente com indicador de umidade | |
IN2012DN03178A (pt) | ||
BR112012005044A2 (pt) | composições que compreendem tramadol e celecoxib no tratamento de dor. | |
CY1115384T1 (el) | Αντι-φλεγμονωδης συνθεση | |
BR112013004562A2 (pt) | 2-óxi-quinolina-3-carboxamidas substituídas como moduladores kcnq2/3 | |
BR112014000634A2 (pt) | métodos para tratamento de incontinência associada com atividade sexual | |
BR112014011481A2 (pt) | hidrolisado de colágeno e seu uso | |
BR112013004721A2 (pt) | "quinolina-3-carboxamidas substituídas como moduladores de kcnq2/3" |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
B07B | Technical examination (opinion): publication cancelled [chapter 7.2 patent gazette] | ||
B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
B06T | Formal requirements before examination [chapter 6.20 patent gazette] | ||
B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 26/01/2021, OBSERVADAS AS CONDICOES LEGAIS. |
|
B16C | Correction of notification of the grant [chapter 16.3 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 03/06/2010 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF |